TDOC
TELADOC HEALTH, INC.Marquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates | Q1 2021 | 22Q | $294 | $7.55 | -97% |
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $7.15 | $7.55 | +6% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $6.79 | $7.55 | +11% |
| D.E. Shaw re-entered | Q3 2024(8Q snapshot) | 7Q | $6.79 | $7.55 | +11% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $6.79 | $7.55 | +11% |
| Point72 Asset Management | Q3 2024(8Q snapshot) | 7Q | $6.79 | $7.55 | +11% |
| Two Sigma Investments | Q1 2025(8Q snapshot) | 5Q | $14 | $7.55 | -47% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Millennium Management 3× in & out | Q4 2025 | Q1 2026 | — | +0% |
| Maverick Capital 3× in & out | Q1 2023 | Q4 2024 | → $8.96 | -71% |
| Tiger Global | Q2 2017 | Q2 2018 | → $49 | +70% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Teladoc Health, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 4, 2026 — the most recent Form 4 on file — not from today.
- Form 40002037547-26-000006Jun 4, 2026
- Form 40002037547-26-000004Jun 3, 2026
- Form 40001375088-26-000004Jun 3, 2026
- Form 40002037711-26-000004Jun 3, 2026
- Form 40001347535-26-000006Jun 3, 2026
- Form 40001714468-26-000008Jun 3, 2026
- Form 40002036989-26-000006Jun 3, 2026
- Form 40001756253-26-000002May 21, 2026
- Form 40001624004-26-000002May 21, 2026
- Form 40001302954-26-000002May 21, 2026
- Form 40001174459-26-000002May 21, 2026
- Form 40001804442-26-000002May 21, 2026
- Form 40001203676-26-000002May 21, 2026
- Form 40001714468-26-000006Apr 3, 2026
- Form 40001158584-26-000008Apr 1, 2026
Fundamentals
XBRL · TELADOC HEALTH, INC.Annual figures sourced directly from TELADOC HEALTH, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Teladoc Health, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 21, 2026
- 10-QQuarterly reportApr 30, 2026
- 8-KMaterial eventApr 29, 2026
- DEF 14AProxy statementApr 7, 2026
- 8-KMaterial eventMar 30, 2026
- 10-KAnnual reportFeb 26, 2026
- 8-KMaterial eventFeb 25, 2026
- 8-KMaterial eventFeb 18, 2026
- 8-KMaterial eventFeb 12, 2026
- 8-KMaterial eventDec 16, 2025
- 8-KMaterial eventDec 12, 2025
- 10-QQuarterly reportOct 30, 2025
- 8-KMaterial eventOct 29, 2025
- 8-KMaterial eventOct 23, 2025
- 10-QQuarterly reportJul 30, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q4 2025 | Q1 2026 | $0.00 | — | +0% |
| Two Sigma Investments | Q1 2025 | open | $14 | $6.35 | -56% |
| D.E. Shaw | Q4 2024 | open | $0.00 | — | +0% |
| Millennium Management | Q4 2024 | Q2 2025 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | open | $6.79 | $6.35 | -6% |
| D.E. Shaw | Q3 2024 | open | $6.79 | $6.35 | -6% |
| AQR Capital Management | Q3 2024 | open | $6.79 | $6.35 | -6% |
| Millennium Management | Q3 2024 | Q2 2026 | $6.79 | $6.36 | -6% |
| Point72 Asset Management | Q3 2024 | open | $6.79 | $6.35 | -6% |
| Renaissance Technologies | Q3 2024 | open | $7.15 | $6.35 | -11% |
| Maverick Capital | Q1 2023 | Q4 2024 | $30 | $8.96 | -71% |
| Maverick Capital | Q1 2021 | Q2 2021 | $291 | $137 | -53% |
| Bridgewater Associates | Q1 2021 | open | $294 | $7.55 | -97% |
| Maverick Capital | Q3 2020 | Q4 2020 | $188 | $177 | -6% |
| Tiger Global | Q2 2017 | Q2 2018 | $29 | $49 | +70% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.